trial
as of 2026-07-01A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia
NCTId NCT01490567
at a glance
Phase 4 · Unknown
Enrollment 80 (estimated)
Sponsored by Central South University
Primary completion 2012-06
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Unknown
Enrollment
80 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2011-06
Primary completion
2012-06
Eligibility
ALL · 18 Years · 40 Years
Interventions & indications
Sponsors
Central South UniversityLead Sponsor
Investigators
1
Xiaofeng Guo, doctorPrincipal Investigator
Sites
1 total
Changsha, China
Facts & assertions
4 sourced
Enrollment
80
Phase
PHASE4
Primary Completion Date
2012-06
Status
UNKNOWN
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication
investigator
person